Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey

OBJECTIVE: Immune thrombocytopenia (ITP) is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in significant symptoms, such as bleeding, bruising, epistaxis, or petechiae. The thrombopoietin receptor agonist eltrombopag (EPAG) is a second-lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Koca Yozgat, Ayça, Leblebisatan, Göksel, Akbayram, Sinan, Çınar Özel, Simge, Karakaş, Zeynep, Erduran, Erol, Yılmaz, Şebnem, Koçak, Ülker, Ünal, Şule, Özdemir, Gül Nihal, Albayrak, Meryem, Zengin, Emine, Oymak, Yeşim, Bör, Özcan, Çakmaklı, Hasan Fatih, Söker, Murat, Gürlek Gökçebay, Dilek, Tokgöz, Hüseyin, Malbora, Barış, Karaman, Serap, Celkan, Tiraje, Şaşmaz, İlgen, Yaralı, Neşe, Ören, Hale, Ünüvar, Ayşegül, Özbek, Namık Yaşar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463208/
https://www.ncbi.nlm.nih.gov/pubmed/32181630
http://dx.doi.org/10.4274/tjh.galenos.2020.2019.0380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463208/
https://www.ncbi.nlm.nih.gov/pubmed/32181630
http://dx.doi.org/10.4274/tjh.galenos.2020.2019.0380

Ejemplares similares